CRF announces brand new clinical trials for TCT 2024

Tuesday, October 29

DARKNESS

A large randomized trial of orbital atherectomy versus conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation.

This session is presented by Ajay J. Kirtane.

CLEAR SYNERGY (OASIS 9)

A 2×2 factorial randomized controlled trial of colchicine vs. placebo and spironolactone vs. placebo in patients with myocardial infarction: results of the colchicine factor trial.

This session is presented by Sanjit S. Jolly.

INCOMPARABLE

Large-diameter mechanical thrombectomy vs. catheter-directed thrombolysis for the treatment of intermediate-risk pulmonary embolism.

This session will be presented by Wissam A. Jaber.

SIRONA

Direct comparison between sirolimus- and paclitaxel-coated balloon angioplasty in the femoropopliteal artery.

This session will be presented by Ulf Teichgraeber.

Wednesday, October 30

TRISCEND II

Randomized comparison of transcatheteral valve replacement with optimal medical therapy in severe tricuspid regurgitation

This session is presented by Susheel K. Kodali and Suzanne V. Arnold.

FAVOR III Europe

Quantitative flow ratio or fractional flow reserve to control coronary revascularization

This session will be moderated by Birgitte Krogsgaard Andersen.

FLASH

Fully automated quantitative coronary angiography based on artificial intelligence compared with optical coherence tomography as a guide for coronary stent implantation: A multicenter, randomized, controlled non-inferiority study

This session is presented by Jung-Min Ahn.

Current clinical science at TCT 2024

Monday, October 28

DCB-BIF

Comparison of non-conforming balloon with drug-coated balloon angioplasty for side branch stenosis after provisional stent placement in patients with true coronary bifurcation lesions

This session is presented by ShaoLiang Chen.

HELP PCI

Early administration of heparin at first medical contact versus in the catheterization laboratory for STEMI patients undergoing primary percutaneous coronary intervention: a multicenter randomized trial.

This session is presented by Jing Chen.

DRAMA

Randomized comparison of puncture success rates between distal radial access and transradial access in patients with ST-elevation myocardial infarction

This session is presented by Jun-Won Lee.

INFINITY SWEDEHEART Complex PCI

Clinical outcomes at 1 year and 6–12 months in patients with complex lesion subtypes treated with the DynamX Bioadaptor compared to a modern drug-eluting stent

This session is presented by David Erlinge.

CONFIRM-2

Quantitative CT assessment of atherosclerosis and serious adverse events using artificial intelligence: A multicenter international registry

This session will be presented by Alexander Van Rosendael.

Tuesday, October 29

Co-Star

Colchicine in patients with aortic stenosis undergoing transcatheteral aortic valve replacement: a double-blind randomized controlled trial

This session is presented by Thomas Pilgrim.

ACCESS TO TAVI

Randomized comparison of strategies for vascular access closure after transcatheteral aortic valve implantation

This session is presented by Tobias Rheude.

PROTECTED TAVR: US subgroup

Protection against cerebral embolism in the US cohort of the randomized PROTECTED-TAVR trial

This session is presented by Raj Makkar.

RHEIA/PARTNER pooled analysis in women

Transcatheter vs. surgical aortic valve replacement in women: A pooled analysis of the RHEIA and PARTNER 3 trials

This session will be presented by Didier Tchetche.

ALIGN-AR 2 years

Two-year results of transcatheteral aortic valve replacement with the JenaValve Trilogy in high surgical risk patients with moderate-to-severe or severe native aortic regurgitation.

This session will be presented by Torsten P. Vahl.

Wednesday, October 30

GOAL IV

International multicenter randomized evaluation of the Firehawk rapamycin-eluting coronary stent system

This session will be presented by Olivier F. Bertrand.

TARGET DAPT

Prospective, multicenter, open-label, randomized control study of 3-month versus 12-month dual antiplatelet therapy after implantation of the Firehawk biodegradable polymer sirolimus-eluting coronary stent

This session is presented by Junbo Ge.

Clear-IE

Outcomes of percutaneous mechanical aspiration in right-sided infective endocarditis: A multicenter registry

This session is presented by Abdallah El Sabbagh.

CLASP IID 2 years

RCT and registry: Two-year results of transcatheteral edge-to-edge repair for degenerative mitral valve regurgitation

This session is presented by Raj Makkar.

MATTERHORN: Atrial MR subgroup

Transcatheter repair versus surgery for atrial mitral valve regurgitation: results from the MATTERHORN study. This session will be presented by Stephan Baldus.

More information about TCT 2024

Further details on these late breaking sessions are available here.

Click here to read Cardiovascular Business's coverage of TCT 2023 in San Francisco, which includes coverage of live sessions as well as a series of exclusive video interviews.